Healthway tests whether AI can unlock cardiac capacity
Healthway Multi-Specialty Centers, the outpatient-clinic business of Philippine healthcare group Healthway Medical Network, is deploying Tricog Health’s remote cardiac-diagnostic platforms across its clinic network. The agreement will route cardiac test data through the cloud for AI-assisted analysis and remote review by Healthway cardiologists.
The partnership was formalised on 21 July 2026. Healthway announced that the rollout would encompass all its multi-specialty sites, while the same announcement described a network comprising 16 such centres and more than 250 corporate clinics.
A central pool of expertise
Clinics will upload electrocardiograms and two-dimensional echocardiograms to Tricog’s cloud platform. The software, branded as InstaECG and InstaEcho, generates preliminary diagnostic findings before a cardiologist reviews and authorises the final report.
Healthway’s cardiologists maintain clinical control, with authority to refine the software’s interpretation or replace it entirely with their own assessment before approving the final report. Patients can retrieve approved reports via a portal or in hard copy, while clinicians retain access to archived records for subsequent consultations.
By decoupling diagnostic acquisition from analysis, the model alters clinic workflows. Although local facilities still require suitable equipment and trained staff to record valid data, they no longer depend on a cardiologist being physically present whenever a test is performed.
The commercial logic rests on centralising a single specialist pool across multiple locations. Consolidated scheduling could optimize equipment utilization, reduce idle capacity and extend specialised cardiac care beyond locations that can support a resident specialist.
It could also strengthen Healthway’s bargaining position with corporate-health clients. A broader diagnostic footprint offers employers more standardised care while creating another referral route into Healthway’s hospitals and specialist facilities.
Throughput depends on the human layer
Tricog markets InstaEcho with a two-hour turnaround time, backed by a pool of reviewing cardiologists, while its local promotional material indicates that InstaECG reports arrive within minutes of specialist sign-off. These figures reflect baseline product claims rather than guaranteed service-level agreements for Healthway.
This distinction is critical. Accelerating data transmission cannot guarantee faster diagnostic output if demand outstrips the available cardiologist roster. While a pooled queue allocates scarce specialist labor more efficiently, it can also create a network-wide bottleneck during demand surges.
Healthway has not disclosed expected test volumes, dedicated cardiologist capacity or target response times. The commercial terms – whether priced per test, per site, by subscription or another model – also remain undisclosed, leaving investors unable to evaluate the likely cost per report or the utilisation needed to make the rollout economical.
Safeguards become operating requirements
Mandatory cardiologist review and approval reduce the risk that an incorrect AI suggestion becomes the official diagnosis. However, they do not remove the operational burden of auditing false positives, tracking missed conditions or managing differences in test quality across sites.
Echocardiography remains highly sensitive to image acquisition. Tricog says skilled operators must capture standard diagnostic views before upload; sub-optimal images can constrain the service even when cloud processing and specialist review are fast.
Although both parties characterize the platform as secure, their rollout announcement does not identify encryption standards, data-hosting locations, retention rules or incident-response arrangements. These controls matter because the system stores identifiable medical records and makes them available remotely.
Healthway’s test is ultimately one of operational execution rather than software capability. Rigorous demand forecasting, robust clinical staffing and strict quality control could expand diagnostic capacity without duplicating cardiologists at every clinic; if those do not keep pace, rapid data transmission may simply funnel patients into a central specialist queue.